Literature DB >> 28749249

An autopsy-verified case of steroid-responsive encephalopathy with convulsion and a false-positive result from the real-time quaking-induced conversion assay.

Yuichi Hayashi1, Yasushi Iwasaki2, Nobuaki Yoshikura1, Takahiko Asano3, Maya Mimuro2, Akio Kimura1, Katsuya Satoh4, Tetsuyuki Kitamoto5, Mari Yoshida2, Takashi Inuzuka1.   

Abstract

We report an autopsy-verified case of steroid-responsive encephalopathy with convulsion and a false-positive result from the real-time quaking-induced conversion (RT-QUIC) assay. A 61-year-old Japanese man presented with acute onset of consciousness disturbance, and convulsions, but without a past medical or family history of progressive dementia, epilepsy, or prion disease. Brain diffusion and fluid-attenuated inverted recovery MR images revealed edematous cortical hyper-intensity, which diminished after the acute phase. Steroid pulse therapy was partially effective, although he continued to have dementia with myoclonus and psychiatric symptoms, despite resolution of the consciousness disturbance. Cerebrospinal fluid (CSF) analysis revealed a normal cell count, with significantly elevated levels of 14-3-3 protein and total tau protein. In addition, prion protein in the CSF was slowly amplified by the RT-QUIC assay. PRNP gene analysis revealed methionine homozygosity at codon 129 without mutation. The patient died of sudden cardiac arrest at 3 months after the onset of symptoms. The positive result from the RT-QUIC assay led us to suspect involvement of prion disease, although a postmortem assessment revealed that he had pathological changes after convulsion, and no prion disease. This case indicates that convulsion may cause false-positive RT-QUIC results, and that a postmortem evaluation remains the gold standard for diagnosing similar cases.

Entities:  

Keywords:  14–3–3 protein; MRI; anticonvulsant; convulsion; corticosteroid; encephalopathy; postmortem study; prion disease; real-time quaking-induced conversion assay; total tau-protein

Mesh:

Substances:

Year:  2017        PMID: 28749249      PMCID: PMC5553300          DOI: 10.1080/19336896.2017.1345416

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  15 in total

1.  Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion.

Authors:  Ryuichiro Atarashi; Katsuya Satoh; Kazunori Sano; Takayuki Fuse; Naohiro Yamaguchi; Daisuke Ishibashi; Takehiro Matsubara; Takehiro Nakagaki; Hitoki Yamanaka; Susumu Shirabe; Masahito Yamada; Hidehiro Mizusawa; Tetsuyuki Kitamoto; Genevieve Klug; Amelia McGlade; Steven J Collins; Noriyuki Nishida
Journal:  Nat Med       Date:  2011-01-30       Impact factor: 53.440

2.  A multidisciplinary medical network approach is crucial for increasing the number of autopsies for prion disease [Reply to: How can we increase the numbers of autopsies for prion disease? A model system in Japan].

Authors:  Yuichi Hayashi; Takashi Inuzuka
Journal:  J Neurol Sci       Date:  2017-04-06       Impact factor: 3.181

3.  Neuropathologic characteristics of brainstem lesions in sporadic Creutzfeldt-Jakob disease.

Authors:  Yasushi Iwasaki; Yoshio Hashizume; Mari Yoshida; Tetsuyuki Kitamoto; Gen Sobue
Journal:  Acta Neuropathol       Date:  2005-06-03       Impact factor: 17.088

4.  Preserved regional cerebral blood flow in the occipital cortices, brainstem, and cerebellum of patients with V180I-129M genetic Creutzfeldt-Jakob disease in serial SPECT studies.

Authors:  Yuichi Hayashi; Nobuaki Yoshikura; Akira Takekoshi; Megumi Yamada; Takahiko Asano; Akio Kimura; Katsuya Satoh; Tetsuyuki Kitamoto; Takashi Inuzuka
Journal:  J Neurol Sci       Date:  2016-09-22       Impact factor: 3.181

5.  Reply to: Amyotrophic lateral sclerosis with frontotemporal dementia (ALS-FTD) syndrome as a phenotype of Creutzfeldt-Jakob disease (CJD)? A case report.

Authors:  Yuichi Hayashi; Takashi Inuzuka
Journal:  J Neurol Sci       Date:  2017-02-24       Impact factor: 3.181

6.  Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease.

Authors:  T Kitamoto; R W Shin; K Doh-ura; N Tomokane; M Miyazono; T Muramoto; J Tateishi
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

7.  Clinical features of Creutzfeldt-Jakob disease with V180I mutation.

Authors:  K Jin; Y Shiga; S Shibuya; K Chida; Y Sato; H Konno; K Doh-ura; T Kitamoto; Y Itoyama
Journal:  Neurology       Date:  2004-02-10       Impact factor: 9.910

8.  Cerebrospinal fluid tau proteins in status epilepticus.

Authors:  Giulia Monti; Manuela Tondelli; Giada Giovannini; Roberta Bedin; Paolo F Nichelli; Tommaso Trenti; Stefano Meletti; Annalisa Chiari
Journal:  Epilepsy Behav       Date:  2015-05-06       Impact factor: 2.937

9.  Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years.

Authors:  Katharina Stoeck; Pascual Sanchez-Juan; Joanna Gawinecka; Alison Green; Anna Ladogana; Maurizio Pocchiari; Raquel Sanchez-Valle; Eva Mitrova; Theodor Sklaviadis; Jerzy Kulczycki; Dana Slivarichova; Albert Saiz; Miguel Calero; Richard Knight; Adriano Aguzzi; Jean-Louis Laplanche; Katell Peoc'h; Gabi Schelzke; Andre Karch; Cornelia M van Duijn; Inga Zerr
Journal:  Brain       Date:  2012-09-25       Impact factor: 13.501

10.  Stability and Reproducibility Underscore Utility of RT-QuIC for Diagnosis of Creutzfeldt-Jakob Disease.

Authors:  Maria Cramm; Matthias Schmitz; André Karch; Eva Mitrova; Franziska Kuhn; Bjoern Schroeder; Alex Raeber; Daniela Varges; Yong-Sun Kim; Katsuya Satoh; Steven Collins; Inga Zerr
Journal:  Mol Neurobiol       Date:  2015-04-01       Impact factor: 5.590

View more
  10 in total

1.  Pathological examination is required for the case of rapidly progressive dementia with only positive result of RT-QUIC assay.

Authors:  Yuichi Hayashi
Journal:  Prion       Date:  2017-12-14       Impact factor: 3.931

2.  Design, implementation, and interpretation of amplification studies for prion detection.

Authors:  Nicholas J Haley; Jürgen A Richt; Kristen A Davenport; Davin M Henderson; Edward A Hoover; Matteo Manca; Byron Caughey; Douglas Marthaler; Jason Bartz; Sabine Gilch
Journal:  Prion       Date:  2018-03-09       Impact factor: 3.931

3.  Experimental Bovine Spongiform Encephalopathy in Squirrel Monkeys: The Same Complex Proteinopathy Appearing after Very Different Incubation Times.

Authors:  Pedro Piccardo; Juraj Cervenak; Wilfred Goldmann; Paula Stewart; Kitty L Pomeroy; Luisa Gregori; Oksana Yakovleva; David M Asher
Journal:  Pathogens       Date:  2022-05-20

4.  Clinical findings of a probable case of MM2-cortical-type sporadic Creutzfeldt-Jakob disease with antibodies to anti-N-terminus of α-enolase.

Authors:  Yuichi Hayashi; Megumi Yamada; Akio Kimura; Takahiko Asano; Katsuya Satoh; Tetsuyuki Kitamoto; Makoto Yoneda; Takashi Inuzuka
Journal:  Prion       Date:  2017-10-30       Impact factor: 3.931

Review 5.  Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease.

Authors:  Peter Hermann; Brian Appleby; Jean-Philippe Brandel; Byron Caughey; Steven Collins; Michael D Geschwind; Alison Green; Stephane Haïk; Gabor G Kovacs; Anna Ladogana; Franc Llorens; Simon Mead; Noriyuki Nishida; Suvankar Pal; Piero Parchi; Maurizio Pocchiari; Katsuya Satoh; Gianluigi Zanusso; Inga Zerr
Journal:  Lancet Neurol       Date:  2021-03       Impact factor: 44.182

Review 6.  Towards an improved early diagnosis of neurodegenerative diseases: the emerging role of in vitro conversion assays for protein amyloids.

Authors:  Niccolò Candelise; Simone Baiardi; Alessia Franceschini; Marcello Rossi; Piero Parchi
Journal:  Acta Neuropathol Commun       Date:  2020-07-25       Impact factor: 7.801

7.  Steroid-responsive encephalopathy with a peculiar CSF biomarker profile in an 89-year-old man.

Authors:  Jussi O T Sipilä; Eero Rissanen; Jaana Korpela; Markku Päivärinta
Journal:  Oxf Med Case Reports       Date:  2018-09-24

Review 8.  Sporadic Creutzfeldt-Jakob disease: Real-Time Quaking Induced Conversion (RT-QuIC) assay represents a major diagnostic advance.

Authors:  Federico Angelo Cazzaniga; Edoardo Bistaffa; Chiara Maria Giulia De Luca; Giuseppe Bufano; Antonio Indaco; Giorgio Giaccone; Fabio Moda
Journal:  Eur J Histochem       Date:  2021-10-15       Impact factor: 3.188

9.  Validation of Revised International Creutzfeldt-Jakob Disease Surveillance Network Diagnostic Criteria for Sporadic Creutzfeldt-Jakob Disease.

Authors:  Neil Watson; Peter Hermann; Anna Ladogana; Angeline Denouel; Simone Baiardi; Elisa Colaizzo; Giorgio Giaccone; Markus Glatzel; Alison J E Green; Stéphane Haïk; Daniele Imperiale; Janet MacKenzie; Fabio Moda; Colin Smith; David Summers; Dorina Tiple; Luana Vaianella; Gianluigi Zanusso; Maurizio Pocchiari; Inga Zerr; Piero Parchi; Jean-Philippe Brandel; Suvankar Pal
Journal:  JAMA Netw Open       Date:  2022-01-04

10.  RT-QuIC: a new test for sporadic CJD.

Authors:  Alison J E Green
Journal:  Pract Neurol       Date:  2018-10-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.